TB500 Fragment (1723), also known as fequesetide, is a highpurity, research-grade heptapeptide derived from the active domain of thymosin beta4 (TB4), engineered to model actin regulation, cell migration, and tissue repair in controlled experimental systems
Patients with pre-existing constipation, those taking other medications that slow gut motility (such as opioids or anticholinergics), and individuals with inadequate fluid or fiber intake face elevated risk
They are not intended for human or animal consumption and are not pharmaceutical products, supplements, or therapeutic agents
The kicker: Shorter lifespan Genetic studies show that variants linked to high Lp(a) correlate with a shorter life expectancy
Through their Semaglutide program, I've lost over 20 pounds and counting so far